2 months ago
JBIO
AnalystsVamil DivanVamil Divan's Stock Forecasts
AnalystsVamil Divan
Analyst Ranking
Top 3%
#140 out of 5165 analysts
Average Return
+21.63%
Win Rate
62%109 out of 176
Risk vs Reward
Poor
Good
Vamil Divan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cabaletta Bio IncCABA | +702.34% | $1.28 | $10.27 | 2022-05-24 - 2023-05-24 | Strong Buy |
Cabaletta Bio IncCABA | +313.27% | $1.96 | $8.10 | 2022-03-17 - 2023-03-17 | Strong Buy |
Insmed IncINSM | +265.91% | $20.36 | $74.50 | 2023-07-25 - 2024-07-25 | Strong Buy |
Insmed IncINSM | +185.36% | $26.37 | $75.25 | 2023-09-04 - 2024-09-04 | Strong Buy |
Assembly Biosciences IncASMB | +174.87% | $11.42 | $31.39 | 2025-03-24 - 2026-01-07 | Strong Buy |
Vamil Divan Analyst Color
Get additional color on Vamil Divan's coverage of popular stocks
3 months ago
ABBV
4 months ago
INSM
4 months ago
ASMB
5 months ago
ABBV
6 months ago
JNJ
6 months ago
PROK
8 months ago
ABBV
10 months ago
ANIP
10 months ago
VERA
a year ago
MRK
a year ago
ABBV
a year ago
JNJ
a year ago
ABBV
a year ago
VERA
a year ago
TVTX
a year ago
INSM
2 years ago
VERA
2 years ago
ABBV
2 years ago
ANIP
2 years ago
INSM
2 years ago
PFE
2 years ago
INSM
2 years ago
ANIP
2 years ago
SAGE
Vamil Divan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Insmed IncINSM | 8 | Strong Buy | $221.00 | +25.57% | Maintains | 22 days ago |
Johnson & JohnsonJNJ | 11 | Strong Buy | $227.00 | +9.40% | Maintains | a month ago |
Pfizer IncPFE | 15 | Strong Buy | $35.00 | +38.45% | Maintains | 2 months ago |
Jade Biosciences IncJBIO | 3 | Strong Buy | $17.00 | +28.93% | Maintains | 2 months ago |
Eledon Pharmaceuticals IncELDN | 1 | Strong Buy | $8.00 | +367.84% | Maintains | 2 months ago |
Ani Pharmaceuticals IncANIP | 13 | Strong Buy | $115.00 | +44.71% | Maintains | 2 months ago |
Scynexis IncSCYX | 3 | Strong Buy | $3.00 | +368.02% | Maintains | 2 months ago |
Abbvie IncABBV | 23 | Strong Buy | $242.00 | +3.68% | Maintains | 3 months ago |
Savara IncSVRA | 2 | Strong Buy | $11.00 | +90.64% | Maintains | 4 months ago |
Valneva SeVALN | 2 | Strong Buy | $13.00 | +31.45% | Maintains | 4 months ago |
Assembly Biosciences IncASMB | 2 | Strong Buy | $39.00 | +24.24% | Maintains | 4 months ago |
Prokidney CorpPROK | 2 | Strong Buy | $7.00 | +189.26% | Maintains | 6 months ago |
Amgen IncAMGN | 1 | Hold | $288.00 | -15.70% | Assumes | 8 months ago |
Unicycive Therapeutics IncUNCY | 1 | Strong Buy | $60.00 | +898.34% | Initiates Coverage On | 9 months ago |
Merck & Co IncMRK | 7 | Strong Buy | $115.00 | +5.89% | Reiterates | 9 months ago |
Travere Therapeutics IncTVTX | 7 | Strong Buy | $47.00 | +29.55% | Reiterates | 9 months ago |
Absci CorpABSI | 3 | Strong Buy | $10.00 | +148.76% | Reiterates | 10 months ago |
Vera Therapeutics IncVERA | 5 | Strong Buy | $61.00 | +25.31% | Maintains | 10 months ago |
Revance Therapeutics IncRVNC | 6 | Hold | $3.10 | N/A | Maintains | a year ago |
Keros Therapeutics IncKROS | 2 | Strong Buy | $102.00 | N/A | Maintains | a year ago |
Alpine Immune Sciences IncALPN | 1 | Strong Buy | $55.00 | N/A | Initiates Coverage On | 2 years ago |
Karuna Therapeutics IncKRTX | 7 | Hold | $330.00 | N/A | Downgrades | 2 years ago |
Sage Therapeutics IncSAGE | 7 | Hold | $20.00 | N/A | Maintains | 2 years ago |
Calliditas Therapeutics AbCALT | 2 | Hold | $18.00 | N/A | Maintains | 2 years ago |
Relmada Therapeutics IncRLMD | 2 | Strong Buy | $26.00 | N/A | Reiterates | 3 years ago |
Chinook Therapeutics IncKDNY | 3 | Hold | $40.00 | N/A | Downgrades | 3 years ago |
Satsuma Pharmaceuticals IncSTSA | 5 | Hold | $2.00 | N/A | Downgrades | 3 years ago |
Acadia Pharmaceuticals IncACAD | 7 | Hold | $19.00 | N/A | Maintains | 3 years ago |
Neurocrine Biosciences IncNBIX | 5 | Hold | $98.00 | N/A | Maintains | 3 years ago |
Alkermes PLCALKS | 7 | Strong Buy | $34.00 | N/A | Maintains | 3 years ago |
Cabaletta Bio IncCABA | 3 | Strong Buy | $10.00 | N/A | Maintains | 4 years ago |
Axsome Therapeutics IncAXSM | 3 | Strong Buy | $49.00 | N/A | Maintains | 4 years ago |
Eli Lilly & CoLLY | 12 | Strong Buy | $356.00 | N/A | Maintains | 4 years ago |
Xeris Biopharma Holdings IncXERS | 1 | Strong Buy | $6.00 | N/A | Maintains | 4 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 9 | Strong Buy | $154.00 | N/A | Maintains | 4 years ago |
Evolus IncEOLS | 4 | Strong Buy | $15.00 | N/A | Upgrades | 5 years ago |
Allergan PLCAGN | 9 | Hold | $155.00 | N/A | Maintains | 7 years ago |
Teva Pharmaceutical Industries LtdTEVA | 10 | Hold | $20.00 | N/A | Maintains | 7 years ago |
Galapagos NvGLPG | 3 | Buy | N/A | N/A | Upgrades | 7 years ago |
Portola Pharmaceuticals IncPTLA | 6 | Hold | $30.00 | N/A | Maintains | 7 years ago |
Alder Biopharmaceuticals IncALDR | 2 | Hold | $17.00 | N/A | Maintains | 7 years ago |
Corvus Pharmaceuticals IncCRVS | 3 | Buy | $15.00 | N/A | Assumes | 7 years ago |
Aimmune Therapeutics IncAIMT | 3 | Buy | $40.00 | N/A | Maintains | 7 years ago |
Bristol Myers Squibb CoBMY | 2 | Hold | $61.00 | N/A | Maintains | 7 years ago |
Allena Pharmaceuticals IncALNAQ | 2 | Buy | $21.00 | N/A | Maintains | 8 years ago |
Esperion Therapeutics IncESPR | 2 | Buy | $103.00 | N/A | Initiates Coverage On | 8 years ago |
Myokardia IncMYOK | 1 | Buy | $55.00 | N/A | Maintains | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.